BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2026 7:03:47 AM | Browse: 2 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 118055
Country China
Received
2025-12-23 06:38
Peer-Review Started
2025-12-23 06:38
First Decision by Editorial Office Director
2025-12-31 08:19
Return for Revision
2025-12-31 08:19
Revised
2026-01-06 16:34
Publication Fee Transferred
Second Decision by Editor
2026-02-04 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-04 13:14
Articles in Press
2026-02-04 13:14
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-07-14 07:21
Publish the Manuscript Online
2026-07-24 07:03
ISSN 1948-5182 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Opinion Review
Article Title Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation
Manuscript Source Invited Manuscript
All Author List Shu-Qi Ren and Chuang Cai
ORCID
Author(s) ORCID Number
Shu-Qi Ren http://orcid.org/0009-0004-9589-199X
Chuang Cai http://orcid.org/0000-0002-9660-0160
Funding Agency and Grant Number
Funding Agency Grant Number
Zhongshan Science and Technology Bureau, 2023 No. 2023B1033
Zhongshan Science and Technology Bureau, 2022 No. 2022B1073
Corresponding Author Chuang Cai, PhD, Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, No. 2 Sunwen East Road, Zhongshan 528445, Guangdong Province, China. caich6@foxmail.com
Key Words Interleukin-6/interleukin-10 ratio; Radiofrequency ablation; Hepatic malignancies; Immune dysregulation; Risk stratification; Prognosis
Core Tip The interleukin-6/interleukin-10 ratio stands for an important biological marker of immune abnormality after radio frequency ablation. It independently predicts bad results and thus gives a new direction for postoperative immune observation and risk classification in liver cancer patients.
Publish Date 2026-07-24 07:03
Citation

Ren SQ, Cai C. Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation. World J Hepatol 2026; 18(7): 118055

URL https://www.wjgnet.com/1948-5182/full/v18/i7/118055.htm
DOI https://doi.org/10.4254/wjh.118055
Full Article (PDF) WJH-18-118055-with-cover.pdf
Manuscript File 118055_Auto_Edited_005628.docx
Answering Reviewers 118055-answering-reviewers.pdf
Audio Core Tip 118055-audio.mp3
Conflict-of-Interest Disclosure Form 118055-conflict-of-interest-statement.pdf
Copyright License Agreement 118055-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 118055-non-native-speakers.pdf
Peer-review Report 118055-peer-reviews.pdf
Scientific Misconduct Check 118055-scientific-misconduct-check.png
Scientific Editor Work List 118055-scientific-editor-work-list.pdf
CrossCheck Report 118055-crosscheck-report.pdf